Apheresis Equipment

SKU ID : DA- 27919668

Publishing Date : 29-Jul-2024

No. of pages : 131

PRICE
3360
4200
5040

  • Global apheresis equipment is projected to see considerable growth in coming years. According to the WK-chem Research, “Global Apheresis Equipment Professional Survey Report 2022, Forecast to 2021”, the presence of favorable government initiatives and reimbursement frameworks is expected to boost demand during the forecast period. The compound annual growth rate (CAGR) for the 2022-2021 period is projected to be 11.21% base on WK-chem Research regression analysis model.

    Analysts’ Viewpoint:
    “The market is oligopolistic in nature and characterized by widespread mergers and acquisitions. New product development, acquisitions, and strategic alliances are some of the major sustainability strategies that industry players should adopt”, said Kevin Rose, Senior analyst, in WK Research.

    Market insight:
    The rising prevalence of blood related disorders in developed economies is a major factor stimulating the apheresis equipment industry growth. Blood disorders affect the blood clotting ability of an individual ranging from any age group including infant, adult and elderly population. Moreover, growing population base in Europe are highly susceptible to various blood related disorders such as hemophilia A, hemophilia B, thalassemia and sickle-cell disease among others, thereby augment huge demand for apheresis devices. Additionally, occurrence of rare disease is also known as haemoglobinopathies, which can be addressed by apheresis technique. This could further offer several opportunities for apheresis equipment in healthcare.
    Furthermore, rapid technological advancements in apheresis devices are leading to the development of next-generation apheresis equipment that later contributes to the business revenue share. Also, the device offers automated interface systems, graphical user interface displays and screen navigation that reduces the human intervention. Such technologies provide faster and more effectively results that should augment apheresis devices business growth. However, lack of donor availability and histocompatibility may impede apheresis equipment industry growth during the analysis period.

    Competition Landscape:
    For instance, in October 2020, Haemonetics received US FDA 510(k) approval for its NexSys PCS system with Persona technology. In January 2020, Fresenius Kabi spent EUR 30 million in order to build an apheresis and transfusion disposables plant in the Dominican Republic. This WK-chem Research market report is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading apheresis equipment companies that include: Terumo BCT, Hemacare, Fenwal, Haemonetics, Asahi Kasei Kuraray Medical, B. Braun, Fresenius, Therakos, and Kawasumi Laboratories.

    Segmentation of Apheresis Equipment Market:
    According to the type, the market for apheresis equipment is divided into: Disposable Apheresis Kits and Devices. The disposable apheresis kit segment dominated the market with the most share and is anticipated to maintain its dominance over the forecast period owing to the extensive advancement in the manufacturing of blood bags, disposable kits, and tubing. Growing demand for automated component separation procedures, especially in the developed markets is driving the segment growth.
    According to the technology, the market for apheresis equipment is divided into: Membrane Filtration and Centrifugation. The centrifugation device segment held the largest revenue share. Centrifugation offers faster, simpler, and more precise results as compared to membrane filtration and this attributes to its higher usage rates. Furthermore, growing demand for automated apheresis systems is expected to augment the segment growth.
    According to the application, the market for apheresis equipment is divided into: Renal Diseases, Hematology, Neurology, and Others. The neurology segment accounted for the largest share of revenue. The indispensable need for therapeutic apheresis in the treatment of highly prevalent neurological disorders such as multiple sclerosis and autoimmune neurological disorder are factors attributed to the dominant share of the segment.

    Apheresis Equipment Market: Regional Analysis
    In terms of geography, the global apheresis equipment market has been segmented into: North America, Asia Pacific, Europe, South America, and the Middle East and Africa. Europe market is predictable to show around the most market share over the analysis period. The rising demand for technologically advanced automated products along with favorable reimbursement policies, is the key factor driving the demand for apheresis equipment in this region.
    Asia Pacific apheresis devices industry was valued around the most million. The increasing incidence of blood related disorders in emerging economies due to altering health habits should stimulate the regional market growth. Also, improving investments in the healthcare industry and growing number of skilled practitioners will thereby enhance business growth.

    Frequently Asked Questions



    This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.

    • By product type
    • By End User/Applications
    • By Technology
    • By Region

    The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
    market Reports market Reports